Whereas ovarian cancer is the fifth leading cause of cancer deaths of women in the United States and accounts for more deaths than any other cancer of the female reproductive system; Whereas in the United States, a women’s lifetime risk of being diagnosed with ovarian cancer is about 1 in 78; Whereas the American Cancer Society estimates 21,750 new cases of ovarian cancer will be diagnosed in 2020 and 13,940 people will die from the disease nationwide; Whereas the five-year survival rate for ovarian cancer is 46.5 percent and survival rates vary greatly depending on the stage of diagnosis; Whereas the five-year survival rate for ovarian cancer is over 90 percent for women diagnosed in early stages; Whereas while the mammogram can detect breast cancer and the Pap smear can detect cervical cancer, there is no reliable early detection test for ovarian cancer; Whereas, in June 2007, the first national consensus statement on ovarian cancer symptoms was developed to provide consistency in describing symptoms to make it easier for women to learn and remember those symptoms; Whereas too many people remain unaware that the symptoms of ovarian cancer often include bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, urinary symptoms, and several other vague symptoms that are often easily confused with other diseases; Whereas improved awareness of the symptoms of ovarian cancer by the pubic and health care providers can lead to a quicker diagnosis; Whereas the lack of an early detection test for ovarian cancer combined with its vague symptoms mean that approximately 80 percent of cases of ovarian cancer are detected at an advanced stage; Whereas all women are at risk for ovarian cancer, but approximately 20 percent of women who are diagnosed with ovarian cancer have a hereditary predisposition to ovarian cancer, which places them at even higher risk